ibrutinib,rituximab
abbvie,janssen
[]
the time has come for the triangle study! n 1 abstract #ash22 presented by prof. martin dreyling at the plenary session! full house here!! 
Hematologist at @hvhebron Lymphoma Unit & Hematological Diagnosis @Hemato_Vhebron and @labclinicsvh Barcelona